Latest News
Commerzbank (ETR:CBK) CEO Bettina Orlopp said the lender is entering a new phase as regulatory approvals related to UniCredit’s investment are expected by the end of the year or early next year, while emphasizing that the bank remains independently managed and focused on meeting its existing financi
Via MarketBeat · September 27, 2026
Mining stocks are back in favour driven by higher average realized prices as gold, silver, and copper gained steam and hit record high.
Via The Motley Fool · September 27, 2026
Many stocks in the nuclear space have lost ground this year.
Via The Motley Fool · September 27, 2026
The average investor out there can learn so much from the Oracle of Omaha, even though his role has changed.
Via The Motley Fool · September 27, 2026
CAVA stock fell alongside restaurant peers after weak August traffic data, but Q2 results showed strong sales and unit growth despite slipping margins and a still-rich valuation.
Via MarketBeat · September 27, 2026
Three top Canadian stocks just posted strong results, yet their shares have pulled back. Here's why $500 could work hard in each of them this September.
Via The Motley Fool · September 27, 2026
The company's deliveries report is eagerly awaited, as it offers a sneak peek at its third-quarter earnings.
Via The Motley Fool · September 27, 2026
The medical device giant grew its top line by a double-digit percentage in the first quarter of its fiscal 2027.
Via The Motley Fool · September 27, 2026
Here are three top dividend stocks that could be excellent additions to your TFSA.
Via The Motley Fool · September 27, 2026
A projected well-above-average Social Security raise in 2027 should lead to some unique situations for beneficiaries.
Via The Motley Fool · September 27, 2026
Before jumping in, do the math.
Via The Motley Fool · September 27, 2026
Brookfield Infrastructure Partners is a top "set and forget" dividend stock for growing income. Here's why.
Via The Motley Fool · September 27, 2026
If the artificial intelligence revolution doesn't live up to the hype, the whole market is going to feel it.
Via The Motley Fool · September 27, 2026
Arianespace was Amazon's last chance to keep its Leo satellite constellation growing this year. No longer.
Via The Motley Fool · September 27, 2026
Prestige Consumer Healthcare (NYSE:PBH) said its strategy centers on investing in established over-the-counter brands, maintaining a high-margin operating model and using free cash flow for debt reduction, acquisitions and other shareholder-value initiatives.
Speaking at a fireside chat, Chief Fina
Via MarketBeat · September 27, 2026
Canada’s “energy superpower” pitch isn’t just about resources; it’s about the pipes, fuel, and wires that turn them into exports.
Via The Motley Fool · September 27, 2026
SPY's tech-heavy structure and RSP's equal-weight, rate-sensitive value tilt carry different risks; comparing yields, valuations, and margins helps investors position portfolios for shifting Treasury rates.
Via MarketBeat · September 27, 2026
Investors have an increasingly attractive income and growth opportunity in PepsiCo stock.
Via The Motley Fool · September 27, 2026
The company's shares may have peaked at $341 per share.
Via The Motley Fool · September 27, 2026
A little over half of Americans own stock, which means that too many people are missing out on the wealth-building power of capitalism.
Via The Motley Fool · September 27, 2026
There's one sure-fire way to know when to claim, but you will still have to settle for a best guess.
Via The Motley Fool · September 27, 2026
AMD, Credo Technologies, Bloom Energy, Target and LightPath Technologies show bullish chart setups and fundamental tailwinds ahead of Q3 earnings that could fuel gains by year's end.
Via MarketBeat · September 27, 2026
Several fast-growing cryptocurrencies have the potential to overtake Bitcoin. But can they maintain their momentum over the long haul?
Via The Motley Fool · September 27, 2026
The growth stocks of smaller companies could be the next big opportunity.
Via The Motley Fool · September 27, 2026
Kamada (NASDAQ:KMDA) outlined its growth strategy, product portfolio and financial outlook during a company presentation, emphasizing demand for specialty plasma-derived therapies and a plan to expand through product sales, distribution agreements, plasma supply and potential acquisitions.
The comp
Via MarketBeat · September 27, 2026